ESTRELLA IMMUNOPHARMA, INC. (ESLAW) Operating cash flow 2021–2025
ESTRELLA IMMUNOPHARMA, INC. (ESLAW) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$1.8MFY2025 · since FY2021: -$316,158 → -$1.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$1.8M | +88.9% |
| FY2024 | -$16.1M | -1102.6% |
| FY2023 | -$1.3M | -28.0% |
| FY2022 | -$1.0M | -230.2% |
| FY2021 | -$316,158 | — |
Source: SEC XBRL filings · For reference only · Not investment advice